How to Get Soliris (Eculizumab) Covered by Cigna in Washington: Complete Prior Authorization Guide and Appeal Process
Answer Box: Getting Soliris Covered by Cigna in Washington
To get Soliris (eculizumab) covered by Cigna in Washington, you need: (1) Complete prior authorization with diagnosis confirmation, vaccination records, and specialist documentation; (2) Submit via Cigna's provider portal or fax to 855.840.1678; (3) If denied, use Washington's strong external review process through the Insurance Commissioner within 180 days. Start today: Contact your specialist to gather required clinical documentation and confirm meningococcal vaccination status. Washington residents have binding external review rights that often overturn initial denials.
Table of Contents
- Who Should Use This Guide
- Member & Plan Basics
- Clinical Criteria Checklist
- Documentation Requirements
- Submission Process
- Specialty Pharmacy Setup
- After Submission: Tracking Your Request
- Appeals Process in Washington
- Common Denial Reasons & Solutions
- Cost Assistance Programs
- Frequently Asked Questions
Who Should Use This Guide
This guide is for Washington residents with Cigna coverage who need Soliris (eculizumab) for FDA-approved conditions: paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis with positive acetylcholine receptor antibodies, or neuromyelitis optica spectrum disorder with positive aquaporin-4 antibodies.
Expected outcome: With proper documentation, most clinically appropriate requests get approved. If initially denied, Washington's external review process has helped many patients access rare disease medications through independent medical review.
Member & Plan Basics
Coverage Requirements
- Active Cigna coverage with prescription benefits
- Prior authorization required for all Soliris indications
- Specialty pharmacy mandate: Must use Cigna's preferred specialty pharmacy (typically Accredo)
- Site of care restrictions: Cigna may require justification for infusion location
Plan Type Considerations
- Commercial plans: Follow standard PA process outlined below
- Medicare Advantage: Similar requirements with potential additional documentation
- Self-funded employer plans: May have different appeal rights (contact U.S. Department of Labor if needed)
Clinical Criteria Checklist
Diagnosis-Specific Requirements
| Condition | Required Documentation | Specialist Requirement |
|---|---|---|
| PNH | Flow cytometry showing GPI-anchored protein deficiency | Hematologist |
| aHUS | Clinical diagnosis; rule out Shiga toxin E. coli HUS | Hematologist/Nephrologist |
| gMG | AChR+ antibodies, MG-ADL score ≥6, MGFA class II-IV | Neurologist |
| NMOSD | AQP4+ antibodies, clinical evidence | Neurologist |
Universal Requirements
- Age restriction: 18+ for gMG and NMOSD
- Vaccination: Meningococcal vaccines (MenACWY and MenB) ≥2 weeks before treatment
- REMS enrollment: Prescriber must be enrolled in Soliris REMS program
Step Therapy Requirements
- PNH/aHUS: No step therapy typically required (first-line treatment)
- gMG/NMOSD: Must document failure/intolerance of ≥2 immunosuppressive therapies
Documentation Requirements
Medical Necessity Letter Components
Your specialist should include:
- Confirmed diagnosis with supporting test results
- Disease severity and functional impact
- Prior treatments attempted and outcomes
- Clinical rationale for Soliris specifically
- Treatment goals and monitoring plan
- Vaccination status and safety considerations
Required Attachments
- Recent laboratory results
- Imaging studies (if applicable)
- Prior therapy documentation
- Vaccination records
- Specialist consultation notes
Tip: Incomplete documentation is the #1 cause of delays. Ensure all required elements are included before submission.
Submission Process
Step-by-Step Submission
- Download current PA form from Cigna provider resources
- Complete all required fields (patient info, diagnosis codes, clinical rationale)
- Attach supporting documentation listed above
- Submit via:
- Fax: 855.840.1678
- Online: CoverMyMeds portal
- EHR integration: If available
- For urgent cases: Call 800.882.4462 after submission
Timeline Expectations
- Standard review: 72 hours to 5 business days
- Expedited review: 24-72 hours (for urgent medical situations)
- Additional information requests: May extend timeline by 5-10 days
Specialty Pharmacy Setup
Accredo Enrollment Process
- Prescriber completes Accredo enrollment form
- Fax to Accredo: 888.302.1028
- Patient receives welcome call for insurance verification
- Coordinate shipment and nursing support if needed
Transfer from Another Pharmacy
- New prescription required (cannot transfer specialty medications)
- Coordinate timing to avoid treatment gaps
- Verify insurance approval before shipment
After Submission: Tracking Your Request
What to Track
- Confirmation number from submission
- Review timeline (standard vs. expedited)
- Additional information requests
- Decision notification method
Status Check Schedule
- Day 3: If no confirmation received, call Cigna
- Day 7: Follow up if no decision
- Day 14: Escalate if still pending
Appeals Process in Washington
Washington residents have strong appeal rights that often result in coverage approval for medically necessary treatments.
Internal Appeals with Cigna
| Appeal Level | Timeline to File | Cigna Decision Time | Requirements |
|---|---|---|---|
| First Level | 180 days from denial | 30 days (72h expedited) | Appeal letter + clinical documentation |
| Second Level | Within 180-day window | 30 days | Additional evidence recommended |
| Peer-to-Peer | Within 30 days of denial | Immediate discussion | Doctor-to-doctor review |
External Review (Washington State)
After exhausting internal appeals, you can request binding external review:
- File within: 180 days of final Cigna denial
- Contact: Washington Insurance Commissioner at 1-800-562-6900
- Decision timeline: 30 days (72 hours expedited)
- Cost: Free to patient
- Outcome: Binding on Cigna if overturned
From our advocates: We've seen many Washington patients successfully overturn Cigna denials for rare disease medications through external review. The key is providing comprehensive clinical evidence that demonstrates medical necessity according to current treatment guidelines, not just the insurer's internal policies.
Common Denial Reasons & Solutions
| Denial Reason | Solution | Documentation Needed |
|---|---|---|
| Missing vaccination proof | Submit vaccination records | Meningococcal vaccine documentation |
| Incomplete diagnosis confirmation | Provide definitive test results | Flow cytometry (PNH), antibody tests (gMG/NMOSD) |
| Insufficient prior therapy documentation | Detail previous treatments | Medication lists, response/intolerance notes |
| Site of care not approved | Justify infusion location | Medical necessity for specific setting |
| Not medically necessary | Strengthen clinical rationale | Updated specialist letter, guidelines citations |
Cost Assistance Programs
Manufacturer Support
- Alexion Access Navigator: Patient support services
- Copay assistance: May be available for commercially insured patients
- Free drug programs: For uninsured/underinsured patients
State and Foundation Resources
- Washington Apple Health: Medicaid coverage for eligible residents
- Patient Access Network Foundation: Grants for specialty medications
- HealthWell Foundation: Copay assistance programs
Counterforce Health helps patients navigate insurance denials by creating targeted, evidence-based appeals that turn rejections into approvals. Our platform analyzes your specific denial and generates customized appeal letters that address payer requirements while incorporating the latest clinical evidence.
Frequently Asked Questions
Q: How long does Cigna prior authorization take for Soliris in Washington? A: Standard reviews take 72 hours to 5 business days. Expedited reviews for urgent cases are completed within 24-72 hours.
Q: What if Soliris is non-formulary on my plan? A: You can request a formulary exception through the same PA process, providing medical necessity justification for why formulary alternatives are inappropriate.
Q: Can I request an expedited appeal in Washington? A: Yes, both Cigna internal appeals and Washington external reviews offer expedited timelines (72 hours) for cases where health could be in serious jeopardy.
Q: Does step therapy apply if I've tried treatments outside Washington? A: Yes, prior therapy documentation from any location counts toward step therapy requirements. Ensure your specialist includes detailed records of previous treatments.
Q: What happens if the external review upholds Cigna's denial? A: The external review decision is final for insurance purposes, but you can still contact the Washington Insurance Commissioner for guidance or consider legal consultation.
Q: Do I need a specialist to prescribe Soliris? A: Yes, Cigna requires prescription by or consultation with relevant specialists: hematologists for PNH/aHUS, neurologists for gMG/NMOSD.
Sources & Further Reading
- Cigna Soliris Coverage Policy
- Soliris FDA Prescribing Information
- Washington State Appeals Guide
- CDC Meningococcal Vaccination Guidelines
- Accredo Specialty Pharmacy
- Alexion Access Navigator
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual medical circumstances and specific insurance plan terms. Always consult with your healthcare provider and insurance plan directly. For personalized assistance with appeals and prior authorizations, consider working with Counterforce Health to maximize your chances of approval.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.